Clinical study of intratumoral injection of dendritic cells

Clinical study of intratumoral injection of dendritic cells - Dendritic cell injection therapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005822

Enrollment

Registered

2011-06-22

Start date

2000-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

advanced GI &amp

Interventions

Inject own dendritic cells into tumor

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Clinically or pathologically diagnosed biliary tract cancer 2.Age between 20 to 80 3.No severe organ function impairment 4.Patients who have unresectable tumors to be refractory to chemotherapy 5.Written informed consent of the patient 6.Performance Status 0-2

Exclusion criteria

Exclusion criteria: 1.Pregnancy or lactation 2.Decision of unsuitableness by principal investigator 3.Patient with severe underlying disease 4.Patient with severe allergy disease

Design outcomes

Primary

Measure	Time frame
Safety Clinical response	—

Countries

Japan

Contacts

Public ContactAtsushi Aruga

Tokyo Women's Medical University Institute of Advanced Biomedial Engineering and Science

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026